Bioptik Technology Incorporation (TPEX:4161)
30.25
-0.60 (-1.94%)
Jun 2, 2025, 1:30 PM CST
TPEX:4161 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 90.29 | 93.57 | 85.71 | 48.5 | 22.59 | -59.99 | Upgrade
|
Depreciation & Amortization | 35.05 | 35.64 | 34.72 | 33.47 | 36.98 | 37.75 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.05 | 0.9 | -0.02 | -0.06 | -0 | -0.07 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | - | 5.65 | Upgrade
|
Loss (Gain) From Sale of Investments | -8.74 | -16.12 | -3.44 | 6.14 | 5.72 | 5.6 | Upgrade
|
Stock-Based Compensation | 8.72 | 8.75 | 5.41 | - | - | - | Upgrade
|
Provision & Write-off of Bad Debts | -0.17 | 0.15 | 0.29 | -0.22 | -0.29 | -1.53 | Upgrade
|
Other Operating Activities | -0.85 | -0.09 | 5.59 | 12.86 | -2.95 | -7.11 | Upgrade
|
Change in Accounts Receivable | 7.51 | 23.7 | -15.25 | 5.18 | -10.64 | 16.78 | Upgrade
|
Change in Inventory | 5.16 | 29.62 | 71.09 | -92.75 | -39.29 | -27.82 | Upgrade
|
Change in Accounts Payable | -32.38 | -28.71 | 12.81 | -31.96 | 34.75 | -1.68 | Upgrade
|
Change in Other Net Operating Assets | 41.55 | 11.41 | 9.03 | 73.9 | -92.09 | 34.08 | Upgrade
|
Operating Cash Flow | 133.03 | 158.82 | 205.95 | 55.06 | -41.15 | 6.57 | Upgrade
|
Operating Cash Flow Growth | -26.93% | -22.88% | 274.07% | - | - | -83.98% | Upgrade
|
Capital Expenditures | -7.78 | -14.93 | -30.42 | -16.93 | -19.14 | -13.03 | Upgrade
|
Sale of Property, Plant & Equipment | 0.07 | 0.07 | 0.38 | 0.06 | 0.01 | 0.6 | Upgrade
|
Sale (Purchase) of Intangibles | -2.02 | -0.58 | -0.62 | -0.15 | -0.69 | -0.15 | Upgrade
|
Investment in Securities | 2.35 | 2.35 | 2.53 | 204.16 | -98.8 | -119.11 | Upgrade
|
Other Investing Activities | 0.15 | 0.66 | -0.41 | -0 | - | -1.14 | Upgrade
|
Investing Cash Flow | -7.23 | -12.44 | -28.53 | 187.14 | -118.61 | -132.83 | Upgrade
|
Short-Term Debt Issued | - | 690 | 1,082 | 990 | 610 | 830 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | - | 2 | Upgrade
|
Total Debt Issued | 675 | 690 | 1,082 | 990 | 610 | 832 | Upgrade
|
Short-Term Debt Repaid | - | -760 | -1,182 | -970 | -550 | -830 | Upgrade
|
Long-Term Debt Repaid | - | -26.2 | -44.08 | -41.12 | -41.25 | -33.47 | Upgrade
|
Total Debt Repaid | -811.22 | -786.2 | -1,226 | -1,011 | -591.25 | -863.47 | Upgrade
|
Net Debt Issued (Repaid) | -136.22 | -96.2 | -144.08 | -21.12 | 18.76 | -31.47 | Upgrade
|
Issuance of Common Stock | - | - | 24 | - | - | - | Upgrade
|
Repurchase of Common Stock | -1.07 | -1.07 | - | - | - | - | Upgrade
|
Common Dividends Paid | -37.09 | -37.09 | - | -14.48 | -14.48 | -28.96 | Upgrade
|
Other Financing Activities | - | - | 0.75 | 0.04 | 1.38 | - | Upgrade
|
Financing Cash Flow | -174.38 | -134.36 | -119.33 | -35.56 | 5.65 | -60.43 | Upgrade
|
Foreign Exchange Rate Adjustments | 0 | 0.02 | -0.01 | 0.01 | -0.01 | 0.1 | Upgrade
|
Net Cash Flow | -48.58 | 12.05 | 58.08 | 206.65 | -154.12 | -186.6 | Upgrade
|
Free Cash Flow | 125.25 | 143.9 | 175.53 | 38.13 | -60.29 | -6.46 | Upgrade
|
Free Cash Flow Growth | -14.47% | -18.02% | 360.35% | - | - | - | Upgrade
|
Free Cash Flow Margin | 14.89% | 16.63% | 21.19% | 4.97% | -8.17% | -1.33% | Upgrade
|
Free Cash Flow Per Share | 2.40 | 2.77 | 3.42 | 0.75 | -1.19 | -0.13 | Upgrade
|
Cash Interest Paid | 8.7 | 9.13 | 11 | 9.19 | 7.82 | 8.47 | Upgrade
|
Cash Income Tax Paid | 17.57 | 17.72 | 14.97 | 0.43 | 0.1 | 3.04 | Upgrade
|
Levered Free Cash Flow | 126.83 | 115.68 | 133.43 | 2.52 | -72.18 | 7.13 | Upgrade
|
Unlevered Free Cash Flow | 132.27 | 121.38 | 140.3 | 8.26 | -67.29 | 12.42 | Upgrade
|
Change in Net Working Capital | -35.99 | -36.34 | -75 | 32.8 | 106.78 | -14.25 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.